On Nov 3, 2021 ANI Pharmaceuticals closed a Post-IPO Equity round and raised $75,000,000 from investors, featuring lead investors .

About the company: ANI Pharmaceuticals is located at United States, North America.
“ANI Pharmaceuticals is an integrated specialty pharmaceutical company developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals.”

Company website: http://www.anipharmaceuticals.com